Overview

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

Status:
Completed
Trial end date:
2021-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of a treat to target strategy coupled with early endoscopic assessment versus a clinically driven (routine care) approach in achieving endoscopic response.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen-Cilag Ltd.
Treatments:
Ustekinumab